Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript
Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript November 12, 2025Immuneering Corporation misses on earnings expectations. Reported EPS is $-0.38 EPS, expectations were $-0.37.


